Previous close | 6.20 |
Open | 5.83 |
Bid | 5.70 |
Ask | 5.85 |
Strike | 150.00 |
Expiry date | 2025-01-17 |
Day's range | 5.83 - 5.85 |
Contract range | N/A |
Volume | |
Open interest | 5.09k |
Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.
In this article, we discuss 15 best S&P 500 dividend stocks to buy now. You can skip our detailed analysis of dividend stocks in the S&P 500 and their past performance, and go directly to read 5 Best S&P 500 Dividend Stocks To Buy Now. It’s been a dynamic first quarter for the stock market. […]